Literature DB >> 29972745

Moving Addiction Care to the Mainstream - Improving the Quality of Buprenorphine Treatment.

Brendan Saloner1, Kenneth B Stoller1, G Caleb Alexander1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29972745      PMCID: PMC6522243          DOI: 10.1056/NEJMp1804059

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  12 in total

1.  The Washington State Hub and Spoke Model to increase access to medication treatment for opioid use disorders.

Authors:  Sharon Reif; Mary F Brolin; Maureen T Stewart; Thomas J Fuchs; Elizabeth Speaker; Shayna B Mazel
Journal:  J Subst Abuse Treat       Date:  2019-07-19

2.  A predictive risk model for nonfatal opioid overdose in a statewide population of buprenorphine patients.

Authors:  Hsien-Yen Chang; Noa Krawczyk; Kristin E Schneider; Lindsey Ferris; Matthew Eisenberg; Tom M Richards; B Casey Lyons; Kate Jackson; Jonathan P Weiner; Brendan Saloner
Journal:  Drug Alcohol Depend       Date:  2019-06-07       Impact factor: 4.492

3.  Buprenorphine prescribing for opioid use disorder in medical practices: can office-based out-patient care address the opiate crisis in the United States?

Authors:  Taeho Greg Rhee; Robert A Rosenheck
Journal:  Addiction       Date:  2019-07-25       Impact factor: 6.526

4.  A mixed-method comparison of physician-reported beliefs about and barriers to treatment with medications for opioid use disorder.

Authors:  Rebecca L Haffajee; Barbara Andraka-Christou; Jeremy Attermann; Anna Cupito; Jessica Buche; Angela J Beck
Journal:  Subst Abuse Treat Prev Policy       Date:  2020-09-14

5.  Quality of Buprenorphine Care for Insured Adults With Opioid Use Disorder.

Authors:  Kelly E Anderson; Brendan Saloner; Julia Eckstein; Christine E Chaisson; Sarah H Scholle; Lauren Niles; Sydney Dy; G Caleb Alexander
Journal:  Med Care       Date:  2021-05-01       Impact factor: 3.178

6.  Changes in Buprenorphine Treatment After Medicaid Expansion.

Authors:  Mark Olfson; Victoria Shu Zhang; Marissa King; Ramin Mojtabai
Journal:  Psychiatr Serv       Date:  2021-03-18       Impact factor: 4.157

7.  Unintentional drug overdose: Is more frequent use of non-prescribed buprenorphine associated with lower risk of overdose?

Authors:  Robert G Carlson; Raminta Daniulaityte; Sydney M Silverstein; Ramzi W Nahhas; Silvia S Martins
Journal:  Int J Drug Policy       Date:  2020-04-17

8.  Buprenorphine Treatment By Primary Care Providers, Psychiatrists, Addiction Specialists, And Others.

Authors:  Mark Olfson; Victoria Zhang; Michael Schoenbaum; Marissa King
Journal:  Health Aff (Millwood)       Date:  2020-06       Impact factor: 9.048

9.  Building a Group-Based Opioid Treatment (GBOT) blueprint: a qualitative study delineating GBOT implementation.

Authors:  Randi Sokol; Mark Albanese; Aaronson Chew; Jessica Early; Ellie Grossman; David Roll; Greg Sawin; Dominic J Wu; Zev Schuman-Olivier
Journal:  Addict Sci Clin Pract       Date:  2019-12-27

Review 10.  The Impact of Stigma on People with Opioid Use Disorder, Opioid Treatment, and Policy.

Authors:  Ali Cheetham; Louisa Picco; Anthony Barnett; Dan I Lubman; Suzanne Nielsen
Journal:  Subst Abuse Rehabil       Date:  2022-01-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.